News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NIH Awards Penn State CTSI $28.2M to Improve Rural Health
September 1, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival
August 31, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
An Itch to Scratch: NCATS, NIDCR Scientists Identify Potential New Approach to Chronic Problem
February 22, 2022 - NCATS News
- Preclinical Chemical Biology Laboratory
People with constantly itchy skin, take heart. NCATS and National Institute of Dental and Craniofacial Research scientists report that blocking a receptor on the surface of spinal cord neurons may help relieve the chronic need to scratch. The study appeared online on July 10 in Science Translational Medicine.
Robots Could Spur Use of Stem Cells in the Laboratory and Clinic
February 14, 2022 - NCATS News
- Automation
- Our Impact on Research Operations
- Stem Cell Translation Laboratory (SCTL)
NCATS scientists used robots to automate the culturing of stem cells, thus speeding up the process and bringing stem cells one step closer to clinical use.
NIH-Funded Study Suggests COVID-19 Increases Risk of Pregnancy Complications
February 7, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Pregnant women with COVID-19 appear to be at greater risk for common pregnancy complications — in addition to health risks from the virus — than pregnant women without COVID-19, suggests a study funded by NIH. The study, supported in part by NCATS, included nearly 2,400 pregnant women infected with SARS-CoV-2 and found that those with moderate to severe infection were more likely to have a cesarean delivery, to deliver preterm, to die around the time of birth, or to experience serious illness from hypertensive disorders of pregnancy, postpartum hemorrhage or from infection other than SARS-CoV-2.
International Registry Reveals Risks COVID-19 Poses with Sickle Cell Disease
February 1, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
NCATS-funded CTSA Program researchers developed a collaborative registry that collects data on COVID-19 illness in people with sickle cell disease.
Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
January 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Findings from NIH’s Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients trial show that convalescent plasma taken from people who had recovered from COVID-19 was not more effective than placebo in delivering clinical improvement 14 days and 28 days after treatment began for people hospitalized with COVID-19.
Can Food Ease Symptoms for People with Bipolar Disorders?
October 1, 2021 - Media Coverage
- Clinical and Translational Science Awards (CTSA) Program